A/Prof Gayle Ross will discuss the conventional systemic therapies, recently arrived biologics and targeted small molecules, and where therapies are heading in this masterclass.
Our five-part workshop series on inflammatory skin diseases, kicks off with 'Diagnosing and Treating Common Nail Disorders'. This workshop provides GPs and GP registrars an opportunity to upskill in assessing and managing a variety of nail conditions.
Please join world-renowned International Psoriasis Council Councillor and key opinion leader in psoriasis, Richard Warren, as he discusses the explosion of therapeutic options over the last two decades in psoriasis, what’s currently available, what’s about to become available, and how to use them appropriately.
In this update, Dr Kamaldeep Sandhu will present an overview of the Hyperhidrosis Clinic at Skin Health Institute.
Our second workshop on 'Psoriasis - New Frontiers' in our five-part series of workshops on inflammatory skin diseases provides an overview
of how to overcome diagnostic and clinical challenges associated with psoriasis presentation and assist general practitioners in optimising psoriasis management.
Come and join A/Prof Aaron Robinson as he presents the highlights from the 25th World Congress of Dermatology in Singapore.
The therapeutic landscape for PsA continues to expand. Patients and prescribers now have a wide range of options for disease management. Traditional DMARDs, biologics, and targeted synthetic DMARDs have revolutionised the treatment of PsA, providing improved patient outcomes and quality of life.
Lilly invites you to join international dermatology experts Dr Laura Savage and A/Prof Peter Foley, KOL for an interactive discussion on PsO to PsA.
Our third workshop on 'Acne, Rosacea & Maskne - Clinical Pearls ' in our five-part series of workshops on inflammatory skin diseases provides an overview of the clinical presentation of acne, rosacea & maskne, an assessment of severity and an overview of management options.
This institute update will be presented by Dr Josie Yeatman, dermatologist who runs the Liaison clinic in collaboration with psychiatrist Dr Melissa Thomas.
The PBA Advisory Committee has introduced a risk share (cap) arrangement that may affect the accessibility of new therapies for Atopic Dermatitis. Join us to learn more about RSAs and what clinicians can do to improve their patient's quality of life.
Join us for an engaging conversation with Professor John Kelly and Associate Professor Robert Kelly as they generously recount their professional odysseys, offering insights into their experiences as dermatologists.
Monday: 8am – 6pm
Tuesday: 8am – 6pm
Wednesday: 8am – 6pm
Thursday: 8am – 5pm
Friday: 8am – 5pm
